Compugen (CGEN) Current Deferred Tax Assets (2019 - 2026)
Compugen (CGEN) reported Current Deferred Tax Assets of $2.5 million for Q1 2026, down 9.89% on a YoY basis from $2.8 million in Q1 2025, and down 1.39% sequentially from $2.5 million in Q4 2025.
Compugen (CGEN) Current Deferred Tax Assets (2019 - 2026) Analysis & Trends
Compugen (CGEN) has 8 years of Current Deferred Tax Assets data on file, last reported at $2.5 million in Q1 2026.
- For the quarter ending Q1 2026, Current Deferred Tax Assets fell 9.89% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (down 9.89% YoY), and the FY2025 full-year result was $2.5 million, down 11.33% from the prior year.
- Current Deferred Tax Assets slipped to $2.5 million in Q1 2026, from $2.5 million in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $3.1 million in Q1 2024 to a low of $1.3 million in Q4 2023.
- A 5-year average of $2.3 million and a median of $2.5 million in 2026 frame the typical range for Current Deferred Tax Assets.
- Across the five-year window, Current Deferred Tax Assets declined 27.22% in 2023 and soared 113.92% in 2024, its largest moves.
- Tracing CGEN's Current Deferred Tax Assets over 5 years: stood at $1.8 million in 2022, then decreased by 27.22% to $1.3 million in 2023, then soared by 113.92% to $2.8 million in 2024, then slipped by 11.33% to $2.5 million in 2025, then decreased by 1.39% to $2.5 million in 2026.
- Business Quant data shows CGEN's Current Deferred Tax Assets at $2.5 million in Q1 2026, $2.5 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.49 Mn |
| Mar 31, 2026 | 2.49 Mn |
| Dec 31, 2025 | 2.52 Mn |
| Dec 31, 2025 | 2.52 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.68 Mn |
| Jun 30, 2025 | 2.68 Mn |
| Mar 31, 2025 | 2.76 Mn |
| Mar 31, 2025 | 2.76 Mn |
| Dec 31, 2024 | 2.84 Mn |
| Dec 31, 2024 | 2.84 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Jun 30, 2024 | 3.06 Mn |
| Jun 30, 2024 | 3.06 Mn |
| Mar 31, 2024 | 3.08 Mn |
| Mar 31, 2024 | 3.08 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Dec 31, 2023 | 1.33 Mn |